Beat-AML 2024 ELN-refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy.

Hoff FW, Blum WG, Huang Y, Welkie RL, Swords RT, Traer E, Stein EM, Lin TL, Archer KJ, Patel PA, Collins RH, Baer MR, Duong VH, Arellano ML, Stock W, Odenike O, Redner RL, Kovacsovics T, Deininger MW, Zeidner JF, Olin RL, Smith CC, Foran JM, Schiller GJ, Curran EK, Koenig KL, Heerema NA, Chen T, Martycz M, Stefanos M, Marcus SG, Rosenberg L, Druker BJ, Levine RL, Burd A, Yocum AO, Borate UM, Mims AS, Byrd JC, Madanat YF

Open source

DOI
10.1182/bloodadvances.2024013685
Published
2024 Oct 22
Container
Blood advances
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2024013685,
  title = {Beat-AML 2024 ELN-refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy.},
  author = {Hoff FW and Blum WG and Huang Y and Welkie RL and Swords RT and Traer E and Stein EM and Lin TL and Archer KJ and Patel PA and Collins RH and Baer MR and Duong VH and Arellano ML and Stock W and Odenike O and Redner RL and Kovacsovics T and Deininger MW and Zeidner JF and Olin RL and Smith CC and Foran JM and Schiller GJ and Curran EK and Koenig KL and Heerema NA and Chen T and Martycz M and Stefanos M and Marcus SG and Rosenberg L and Druker BJ and Levine RL and Burd A and Yocum AO and Borate UM and Mims AS and Byrd JC and Madanat YF},
  year = {2024},
  journal = {Blood advances},
  doi = {10.1182/bloodadvances.2024013685},
  url = {https://doi.org/10.1182/bloodadvances.2024013685}
}

RIS

TY  - JOUR
TI  - Beat-AML 2024 ELN-refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy.
AU  - Hoff FW
AU  - Blum WG
AU  - Huang Y
AU  - Welkie RL
AU  - Swords RT
AU  - Traer E
AU  - Stein EM
AU  - Lin TL
AU  - Archer KJ
AU  - Patel PA
AU  - Collins RH
AU  - Baer MR
AU  - Duong VH
AU  - Arellano ML
AU  - Stock W
AU  - Odenike O
AU  - Redner RL
AU  - Kovacsovics T
AU  - Deininger MW
AU  - Zeidner JF
AU  - Olin RL
AU  - Smith CC
AU  - Foran JM
AU  - Schiller GJ
AU  - Curran EK
AU  - Koenig KL
AU  - Heerema NA
AU  - Chen T
AU  - Martycz M
AU  - Stefanos M
AU  - Marcus SG
AU  - Rosenberg L
AU  - Druker BJ
AU  - Levine RL
AU  - Burd A
AU  - Yocum AO
AU  - Borate UM
AU  - Mims AS
AU  - Byrd JC
AU  - Madanat YF
PY  - 2024
JO  - Blood advances
DO  - 10.1182/bloodadvances.2024013685
UR  - https://doi.org/10.1182/bloodadvances.2024013685
ER  - 

APA

FW, H., WG, B., Y, H., RL, W., RT, S., E, T., EM, S., TL, L., KJ, A., PA, P., RH, C., MR, B., VH, D., ML, A., W, S., O, O., RL, R., T, K., MW, D., JF, Z., RL, O., CC, S., JM, F., GJ, S., EK, C., KL, K., NA, H., T, C., M, M., M, S., SG, M., L, R., BJ, D., RL, L., A, B., AO, Y., UM, B., AS, M., JC, B., & YF, M. (2024). Beat-AML 2024 ELN-refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy.. Blood advances. https://doi.org/10.1182/bloodadvances.2024013685

Source records